Back

Potassium uptitration and risk of atrial fibrillation - a prespecified analysis of the POTCAST randomised clinical trial

30 August 2026 (08:51 - 09:09)
Organised by: Logo
Congress Presentation Part of: Predicting atrial fibrillation: promise, limitations, or screening Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Chaoqun Zheng

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on predicting atrial fibrillation: promise, limitations, or screening
Professor R. Schnabel (Hamburg, DE)
Presentation thumbnail
Anthropometric and lifestyle indicators of incident atrial fibrillation in a large, population-based Swedish population
Doctor S. Cederstrom (Stockholm, SE)
Abstract
Presentation thumbnail
AI-derived LA volume index, LA/RA and LA/LV volume ratios from coronary artery calcium scans predict long-term atrial fibrillation and stroke
Doctor A. Azimi (Calgary, CA)
Abstract
Presentation thumbnail
Screen-detected atrial fibrillation prevalence and adherence to therapeutic recommendations in a fully digital nationwide patch-based ECG screening: the NORSCREEN randomised clinical trial
Professor S. Halvorsen (Oslo, NO)
Abstract

Access the full session

Session thumbnail
Predicting atrial fibrillation: promise, limitations, or screening

The Event

Event poster

ESC Congress 2026

30 August 2026 08:51 CET
You may be interested in
thumbnail
Congress Presentation
Changes in myocardial function related to plasma potassium: a POTCAST substudy
12 December 2024
thumbnail
Congress Presentation
Different risk of atrial fibrillation according to the type of cancer: a nationwide population-based study
28 August 2020
thumbnail
Congress Presentation
Magnesium as an coadyuvant treatment for increasing success rate in electrical cardioversion for atrial fibrillation
4 April 2025
thumbnail
Congress Presentation
PCSK9 inhibitors and incidence of arrhythmias in clinical practice: a phase IV multicentric study
18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources